Cepheid
Total Raised
$58.45MInvestors Count
13Deal Terms
2Funding, Valuation & Revenue
7 Fundings
Cepheid has raised $58.45M over 7 rounds.
Cepheid's latest funding round was a Grant for $28M on July 30, 2021.
Cepheid's valuation in November 2016 was $4,000M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/30/2021 | Grant | $28M | 1 | |||
11/5/2016 | Acq - P2P | $4,000M | ||||
6/21/2000 | IPO | |||||
1/6/2000 | Series C | |||||
4/13/1998 | Series B |
Date | 7/30/2021 | 11/5/2016 | 6/21/2000 | 1/6/2000 | 4/13/1998 |
|---|---|---|---|---|---|
Round | Grant | Acq - P2P | IPO | Series C | Series B |
Amount | $28M | ||||
Investors | |||||
Valuation | $4,000M | ||||
Revenue | |||||
Sources | 1 |
Cepheid Deal Terms
2 Deal Terms
Cepheid's deal structure is available for 2 funding rounds, including their Acq - P2P from November 05, 2016.
Round | Acq - P2P | Series B |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - P2P | |||||||||||||||
Series B |
Cepheid Investors
13 Investors
Cepheid has 13 investors. U.S. Department of Health and Human Services invested in Cepheid's Grant funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/30/2021 | 7/30/2021 | 1 Grant | Government | DC | ||
11/5/2016 | 11/5/2016 | 1 Acq - P2P | Corporation | DC | ||
4/13/1998 | 1/6/2000 | 2 Series B, Series C (2000) | Corporation | Minnesota | ||
Investment Bank | New York | |||||
Corporation | Belgium |
First funding | 7/30/2021 | 11/5/2016 | 4/13/1998 | ||
|---|---|---|---|---|---|
Last Funding | 7/30/2021 | 11/5/2016 | 1/6/2000 | ||
Investor | |||||
Rounds | 1 Grant | 1 Acq - P2P | 2 Series B, Series C (2000) | ||
Board Seats | |||||
Type | Government | Corporation | Corporation | Investment Bank | Corporation |
Location | DC | DC | Minnesota | New York | Belgium |
Cepheid Acquisitions
2 Acquisitions
Cepheid acquired 2 companies. Their latest acquisition was OncoMark on December 16, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/16/2021 | Other | $9.9M | Acquired | 4 | ||
10/3/2014 |
Date | 12/16/2021 | 10/3/2014 |
|---|---|---|
Investment Stage | Other | |
Companies | ||
Valuation | ||
Total Funding | $9.9M | |
Note | Acquired | |
Sources | 4 |
Compare Cepheid to Competitors
Thermo Fisher Scientific serves the science sector with a range of products and services. The company offers scientific research tools, biotechnology products, and diagnostic testing equipment, as well as laboratory and pharmaceutical development services. Thermo Fisher Scientific serves the biotech, biopharma, contract development and manufacturing organization (CDMO), lab diagnostics, and industrial and applied sciences sectors. Thermo Fisher Scientific was formerly known as Thermo Electron. It was founded in 2006 and is based in Waltham, Massachusetts.
Mimark focuses on the development of diagnostic solutions for gynecological diseases within the healthcare sector. The company provides a diagnostic approach that utilizes gynecological fluids to assist in the diagnosis of gynecological conditions. Their main products include GyLDEC for endometrial cancer diagnosis and GyLDENDO for endometriosis diagnosis, both of which are based on protein biomarker analysis and designed to be less invasive. It was founded in 2021 and is based in Barcelona, Spain.
Hologic operates as a medical technology company focused on women's health through its diagnostic, surgical, and medical imaging products. The company provides services for the detection, diagnosis, and treatment of health conditions related to female health. Hologic's products are utilized across various sectors in the medical field. It was founded in 1985 and is based in Marlborough, Massachusetts.
Ethicon, operating as a subsidiary of Johnson & Johnson, focuses on advancing surgical care. The company's main offerings include surgical technologies and solutions such as sutures, staplers, energy devices, and digital solutions. It aims to improve and save lives through innovative medical procedures. Ethicon primarily serves the healthcare industry. It was founded in 2010 and is based in Warsaw, Indiana.
Pharmacy Stars focuses on healthcare compliance and quality management within the pharmaceutical sector. The company offers an enterprise system that manages and standardizes compounding compliance in hospitals and infusion centers. Its system addresses the documentation process and regulatory requirements across large scale health systems. It was founded in 2015 and is based in Green Bay, Wisconsin.
Meterbolic conducts metabolic health assessments and preventive healthcare within the medical diagnostics sector. The company offers tests that measure insulin response and other metabolic markers to predict the risk of diabetes and other chronic diseases, which can assist in health management. Meterbolic serves individuals seeking health monitoring and those interested in preventive healthcare. It was founded in 2018 and is based in London, United Kingdom.
Loading...